<DOC>
	<DOCNO>NCT00781456</DOCNO>
	<brief_summary>This study conduct evaluate efficacy 91-day extended cycle oral contraceptive compare placebo decrease frequency severity menstrually-related migraine headache .</brief_summary>
	<brief_title>A Multicenter Study Evaluate Efficacy 91-Day Extended Cycle Oral Contraceptive Menstrually-Related Migraine Headaches</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Premenopausal , nonpregnant , nonlactating History migraine headache without aura least 6 month History migraine headache associate menstruation Others direct FDAapproved protocol History migraine headache aura focal neurological symptom Any contraindication use oral contraceptive Others dictate FDAapproved protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>34 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Migraine headache</keyword>
	<keyword>menstrual</keyword>
	<keyword>oral contraceptive</keyword>
	<keyword>Menstrually-Related Migraine Headache</keyword>
</DOC>